News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,595 Results
Type
Article (2588)
Company Profile (45)
Press Release (37961)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14334)
Career Advice (81)
Deals (2128)
Drug Delivery (9)
Drug Development (4210)
Employer Resources (10)
FDA (451)
Job Trends (786)
News (20494)
Policy (1071)
Tag
Academia (149)
Allergies (7)
Alliances (3527)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (454)
Artificial intelligence (32)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (480)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (30)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (45)
Cancer (329)
Cardiovascular disease (11)
Career advice (69)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (82)
Cervical cancer (2)
Clinical research (3495)
Collaboration (203)
Company closure (2)
Compensation (104)
COVID-19 (187)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (419)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (525)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4530)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6504)
Executive appointments (135)
FDA (596)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (172)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (63)
Government (160)
Guidances (24)
Healthcare (732)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (199)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1011)
IRA (7)
Job creations (293)
Job search strategy (65)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (217)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (317)
Medtech (318)
Mergers & acquisitions (1232)
Metabolic disorders (72)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (164)
NextGen: Class of 2026 (371)
Non-profit (163)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (25)
Peanut (1)
People (5937)
Pharmaceutical (5)
Phase 1 (1504)
Phase 2 (1730)
Phase 3 (922)
Pipeline (391)
Policy (16)
Postmarket research (31)
Preclinical (642)
Press Release (2)
Prostate cancer (8)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (63)
Real estate (427)
Recruiting (5)
Regulatory (927)
Reports (7)
Research institute (164)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (498)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (54)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Last 7 days (40)
Last 30 days (154)
Last 365 days (2426)
2026 (212)
2025 (2453)
2024 (2625)
2023 (2870)
2022 (3780)
2021 (4112)
2020 (3546)
2019 (2098)
2018 (1573)
2017 (1810)
2016 (1642)
2015 (1849)
2014 (1387)
2013 (1200)
2012 (1410)
2011 (1347)
2010 (1190)
Location
Africa (44)
Alabama (3)
Arizona (19)
Asia (1970)
Australia (314)
California (1605)
Canada (242)
China (80)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4081)
Florida (65)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (49)
Massachusetts (577)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (135)
New York (81)
North Carolina (131)
Northern California (784)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (652)
Tennessee (4)
Texas (152)
United States (3221)
Utah (6)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,595 Results for "maxwell biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Maxwell Biosciences Announces Closing of $20M Financing Round
Investment accelerates Maxwell’s path toward FDA trials and global market readiness
August 7, 2025
·
3 min read
Press Releases
Former US Congressman Dr. Brad Wenstrup Joins Maxwell Board
Dr. Brad Wenstrup has broad experience in government, military and civilian medicine and expertise in managing bacterial, fungal and viral infections, key to Maxwell’s vision to create health for the world
November 20, 2025
·
3 min read
Press Releases
Maxwell Biosciences Subsidiary Havih Announces Partnership with the Government of Andhra Pradesh
This partnership will establish a new research and production facility in Andhra Pradesh, driving India’s transition toward pharmaceutical leadership and creating high-tech jobs
December 18, 2025
·
4 min read
Press Releases
Maxwell Biosciences Secures Anti-Diarrheal US Military Agreement
Maxwell’s 7th signed US military agreement is for in vitro testing of Maxwell’s Claromers for the treatment of diarrheal pathogens
April 23, 2025
·
3 min read
Press Releases
Maxwell Biosciences Marks Scientist Appreciation Day With Renewed Call to Recognize Scientists
Company holiday celebrates scientific impact and invites underrecognized researchers to connect
August 18, 2025
·
2 min read
Press Releases
Maxwell Biosciences Announces AI Department & Hiring of Jon McClure
New leadership to spearhead AI-driven breakthroughs in drug discovery and operational excellence
July 17, 2025
·
4 min read
Press Releases
Maxwell Biosciences Secures US Military Research Agreement to Combat Dengue Fever
U.S. Naval Infectious Diseases Diagnostic Laboratory to study dengue fever activity of Claromer antiviral compounds, combatting a rapidly growing mosquito-borne viral infection and a national priority biodefense threat
February 26, 2025
·
4 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Business
Maxwell Biosciences CEO J. Scotch McClure Named Top 25 Executive in Biotechnology
Austin, Texas--(Newsfile Corp. - May 15, 2024) - Maxwell Biosciences, Inc, a pre-clinical drug platform company focused on developing biomimetic therapeutics that improve upon natural immune system peptides...
May 15, 2024
·
2 min read
Press Releases
Maxwell Biosciences Announces Appointment of José Antonio Alas to Its Board of Directors
Appointment of José Antonio Alas brings more than 30 years of biotech expertise, including global business development, international partnerships, patient access to innovative medications and product launches as the company advances its Claromer drug discovery platform
January 22, 2025
·
2 min read
1 of 4,060
Next
